首页 | 本学科首页   官方微博 | 高级检索  
检索        

“一测多评”法测定腰痹通胶囊中5 种皂苷类成分的含量
引用本文:代百东,孙莉琼,李艳静,丁岗,李欣,王振中,毕宇安,萧伟.“一测多评”法测定腰痹通胶囊中5 种皂苷类成分的含量[J].世界科学技术-中医药现代化,2014,16(10):2227-2232.
作者姓名:代百东  孙莉琼  李艳静  丁岗  李欣  王振中  毕宇安  萧伟
作者单位:江苏康缘药业股份有限公司/中药制药过程新技术国家重点实验室 连云港 222001
基金项目:科学技术部国家重大新药创制专项(2013ZX09402203)现代中药创新集群与数字制药技术平台,负责人王振中。
摘    要:目的:建立“一测多评”法测定腰痹通胶囊中皂苷类成分含量的分析方法。方法:以腰痹通胶囊为研究对象,建立参照物人参皂苷Rg1与三七皂苷R1、人参皂苷Re、人参皂苷Rb1、人参皂苷Rd的相对校正因子,分别采用外标法和“一测多评”法测定腰痹通胶囊中5种皂苷类成分的含量,并将两种测定方法的结果进行对比分析,以验证“一测多评”法的合理性、可行性和可重复性。结果:腰痹通胶囊中皂苷类成分间的相对校正因子分别为:f 人参皂苷Rg1/三七皂苷R1=0.999、f人参皂苷Rg1/人参皂苷Re=1.228、f人参皂苷Rg1/人参皂苷Rb1=0.990、f人参皂苷Rg1/人参皂苷Re=1.094。“一测多评”法的计算结果与外标法的实测值之间无显著性差异,实验所得的相对校正因子可信。结论:本实验建立的“一测多评”法可行准确,可以更合理、快速地实现腰痹通胶囊中多种皂苷类成分的质量控制。

关 键 词:一测多评  相对校正因子  人参皂苷  三七皂苷  腰痹通胶囊
收稿时间:2013/12/19 0:00:00
修稿时间:2014/10/18 0:00:00

Simultaneous Determination of Five Saponins in Yao-Bi-Tong Capsules by QAMS
Dai Baidong,Sun Liqiong,Li Yanjing,Ding Gang,Li Xin,Wang Zhenzhong,Bi Yu''an and Xiao Wei.Simultaneous Determination of Five Saponins in Yao-Bi-Tong Capsules by QAMS[J].World Science and Technology-Modernization of Traditional Chinese Medicine,2014,16(10):2227-2232.
Authors:Dai Baidong  Sun Liqiong  Li Yanjing  Ding Gang  Li Xin  Wang Zhenzhong  Bi Yu'an and Xiao Wei
Institution:Jiangsu Kanion Pharmaceutical Co., Ltd., Lianyungang 222001, China; State Key Laboratory of New-tech for Chinese Medicine Phar maceutical Process, Lianyungang 222001, China
Abstract:This study was aimed to establish a quality evaluation method, quantitative analysis of multi-components with a single-marker (QAMS) to determine the contents of five saponins in Yao-Bi-Tong (YBT) capsules. Ginsenoside Rg1 was used as the internal standard; the relative correction factor (RCF) of notoginsenoside R1, ginsenoside Re, ginsenoside Rb1 and ginsenoside Rd were calculated and evaluated. The contents of 5 saponins were determined by the external standard method and QAMS, respectively. Rationality, feasibility and repeatability of the QAMS method were verified by comparing the results obtained from two different methods. The results showed that RCFs of notoginsenoside R1, ginsenoside Re and ginsenoside Rb1 to ginsenoside Rg1 against YBT capsules were 0.999, 1.228, 0.990 and 1.094, respectively, indicating good reproducibility. These results of two methods had no significant difference. It was concluded that the QAMS method can be accurately, rapidly and reasonably used as a new quality assessment model for ginsenosides in YBT capsules.
Keywords:QAMS  relative correction factor  ginsenosides  notoginsenoside  Yao-Bi-Tong capsules
本文献已被 万方数据 等数据库收录!
点击此处可从《世界科学技术-中医药现代化》浏览原始摘要信息
点击此处可从《世界科学技术-中医药现代化》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号